About the speaker: Liesbeth Foesters is a dynamic leader with over 11 years of dedicated service at UCB. Currently serving as the Head of GMP/GSP Quality Operations and Senior Director, she plays a pivotal role within the Quality Leadership Team. Based in Braine-l’Alleud, Belgium, Liesbeth oversees a team of professionals responsible for managing UCB’s Biological & Pharmaceutical portfolio from development to commercialization. With a diverse background that includes international relocations, a strong rapport with suppliers, and a youthful perspective, Liesbeth, at just 37 years old and a mother of three, brings a fresh and dynamic approach to her role. She reports directly to the Chief Quality Officer and is a key player in ensuring the quality and compliance of UCB’s products and operations.

About the company: UCB is a global biopharmaceutical company dedicated to advancing innovative solutions in the field of neurology and immunology. With a rich history spanning decades, UCB focuses on transforming the lives of patients by delivering cutting-edge therapies and treatments. Headquartered in Brussels, Belgium, UCB operates worldwide, combining scientific excellence with a commitment to patient well-being. Their unwavering dedication to research and development has resulted in breakthroughs that address unmet medical needs, making UCB a trusted name in the healthcare industry and a leader in the quest for healthier, happier lives.

Number of Employees: 8,700

Revenue: €5.52 billion